Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S-1 in advanced non-small cell lung cancer
NCT00652561Phase 2Completed
- Sponsor
- Taiho Oncology
- Start
- Feb 2005
- Primary completion
- Nov 2007
- Modality
- Small Molecules
01
Overview
Phase 2, open-label, single-arm trial of tegafur in non-small cell lung cancer (NSCLC), sponsored by Taiho Oncology. Primary endpoint: Overall Response Rate. Started Feb 2005; status: completed.
02
Drugs
tegafur
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00652561.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00652561.